Relafen 750, the novel compound of naproxen, offers a compelling example from the biochemical pharmacy view. Its mechanism of action, mainly involving suppression of cyclooxygenase enzymes and COX-1 and COX-2 – contributes to a lowering in prostaglandin creation. Considering a biochemical context, the drug's effectiveness is directly linked to th